Stockreport

Alumis to Participate in Upcoming September Investor Conferences

Alumis Inc.  (ALMS) 
PDF SOUTH SAN FRANCISCO, Calif., Sept. 03, 2024 (GLOBE NEWSWIRE) -- Alumis Inc. (Nasdaq: ALMS), a clinical-stage biopharmaceutical company developing oral therapies using [Read more]